AI: Is Patenting Really the Right Move? - Factor VII

Patentability Potential & Layered Strategies

Social Media
Download
Download
Read Mode
Subscribe
Summarize

Previous: Factor 6 - Competitor Defensive Positioning

This article forms one part of a broader decision framework for evaluating whether patent or trade secret protection is appropriate for AI innovation.

The framework is designed to help decision-makers (e.g., innovaters, in house, CTOs) align patent and IP strategy with underlying business realities and moving beyond purely "legal" considerations. 

Patentable potential addresses whether the innovation is likely to satisfy the main requirements for patentability: novelty, non-obviousness and subject-matter requirements.

This assessment is highly fact-specific and depends on the prior art landscape and how the invention is framed. Early analysis helps determine whether patent protection is realistic and worth pursuing. For a more in-depth discussion on the topic, we encourage you to review our prior publication Artificial Intelligence Patenting: Top Challenges and Key Considerations.

Horizontal arrow-shaped chart representing a decision spectrum from low patentability (trade secret) to high patentability (patent) 

In a multi-layer analysis, you may choose to proceed with a patent application even if patentability is low, if other factors are in favor of patenting.  For example, if there is a desire to position an application for defensive blocking, that may be reason to proceed even if patentability is in question.

Beyond Patents vs. Trade Secrets: A Layered Strategy

Patent protection decisions are rarely binary. Effective AI portfolios often rely on a layered strategy that aligns different forms of protection with different aspects of the technology. 

  • Patents are typically best suited for externally visible applications, system behavior and technical effects that can be observed, reverse-engineered or independently developed by competitors. 
  • Trade secrets are more appropriate for elements that derive value from remaining hidden, such as training data, data engineering workflows, model tuning strategies and internal performance optimizations. 
  • Contractual controls and internal policies then operate as a supporting layer, reinforcing confidentiality obligations, limiting misuse in partnerships or joint ventures and helping preserve trade secret status over time. As noted in our previous publications, AI companies are strongly advised to deploy internal Trade Secret, Confidentiality and IP Policies as added safeguards (see X.AI Corp. v. OpenAI—Why Every Business (and Start-Up) Needs an Employee Governance Policy for Managing Confidential Business Information and IP Risk).

Applying the Decision Tool: Patents or Trade Secrets

For a further discussion of the decision framework and remaining decision factors in the framework, please see the following:

Framework: Patents or Trade Secrets

Factor 1: Nature of AI Innovation

Factor 2: Enforceable Scope of Patent Protection

Factor 3: Reproducibility of AI Innovation

Factor 4: Business Delivery Model

Factor 5: Commercial Longevity

Factor 6: Competitor Defensive Positioning

If your organization needs assistance evaluating which aspects of its AI innovation are better suited to patent protection versus trade secret protection, our team can help. Our team can also support patent filing and the development of a broader IP strategy.

Social Media
Download
Download
Subscribe
Republishing Requests

For permission to republish this or any other publication, contact Erica Wirthlin at wirthline@bennettjones.com.

For informational purposes only

This publication provides an overview of legal trends and updates for informational purposes only. For personalized legal advice, please contact the authors.

Economic Outlook Mid Year 2026
Update

2026 Mid-Year Economic Outlook

May 27, 2026
Serge Dupont
Serge Dupont
The Impact of Global Trade on the Life Sciences Sector
Blog

The Impact of Global Trade on the Life Sciences Sector

May 26, 2026
Alison G. FitzGeraldNasra Moumin
Alison G. FitzGerald & Nasra Moumin
2026 Life Sciences outlook
Update

Life Sciences Outlook 2026

May 26, 2026
Vincent M. de GrandpréMelissa M. Dimilta
Vincent M. de Grandpré & Melissa M. Dimilta
Life Sciences Collaborations and the Risk of Joint Patent Infringement
Blog

Life Sciences Collaborations and the Risk of Joint Patent Infringement

May 26, 2026
Emily P. KettelVincent M. de Grandpré
Emily P. Kettel & Vincent M. de Grandpré